Orleans Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,475
Closed -$316K 82
2018
Q4
$316K Hold
3,475
0.29% 65
2018
Q3
$342K Sell
3,475
-350
-9% -$32.4K 0.23% 70
2018
Q2
$327K Sell
3,825
-5,403
-59% -$451K 0.24% 72
2018
Q1
$740K Sell
9,228
-21,335
-70% -$1.76M 0.54% 53
2017
Q4
$2.47M Sell
30,563
-400
-1% -$32K 1.76% 26
2017
Q3
$2.41M Sell
30,963
-2,194
-7% -$182K 1.8% 25
2017
Q2
$2.94M Buy
33,157
+250
+0.8% +$21.1K 2.08% 21
2017
Q1
$2.65M Buy
32,907
+400
+1% +$31.2K 1.85% 21
2016
Q4
$2.31M Sell
32,507
-1,020
-3% -$80.1K 1.66% 26
2016
Q3
$2.9M Hold
33,527
2.01% 16
2016
Q2
$2.91M Buy
33,527
+190
+0.6% +$15.4K 2.03% 14
2016
Q1
$2.5M Sell
33,337
-135
-0.4% -$10.2K 1.88% 20
2015
Q4
$2.58M Sell
33,472
-18
-0.1% -$1.35K 1.98% 19
2015
Q3
$2.24M Buy
33,490
+193
+0.6% +$14.2K 1.78% 21
2015
Q2
$2.47M Buy
33,297
+8,393
+34% +$641K 1.74% 21
2015
Q1
$1.94M Buy
24,904
+25
+0.1% +$1.9K 1.26% 37
2014
Q4
$1.8M Sell
24,879
-6,212
-20% -$432K 1.1% 44
2014
Q3
$1.93M Buy
31,091
+880
+3% +$56K 0.95% 50
2014
Q2
$1.93M Buy
30,211
+269
+0.9% +$16.3K 0.9% 50
2014
Q1
$1.84M Buy
29,942
+287
+1% +$16.7K 0.94% 51
2013
Q4
$1.7M Buy
29,655
+1,038
+4% +$58.9K 0.88% 55
2013
Q3
$1.52M Buy
+28,617
New +$1.54M 0.83% 61

Other funds holding MDT

Orleans Capital Management's MDT Position: Q1 2019 in Review

Orleans Capital Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 3,475 shares — an estimated $316K sold.

Orleans Capital Management first reported a position in MDT in Q3 2013 and held it in 22 quarters. The position peaked at $2.94M in Q2 2017. 1,603 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Orleans Capital Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • Orleans Capital Management sold 3,475 Medtronic shares in Q1 2019, an estimated $316K.
  • Orleans Capital Management first reported a position in Medtronic in Q3 2013 and held it in 22 quarters.
  • Orleans Capital Management's Medtronic position peaked at $2.94M in Q2 2017.
  • 1,603 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Orleans Capital Management's 13F filing for Q1 2019, filed 15 May 2019.